查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1975281

全球DNA诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

Global DNA Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

DNA诊断市场预计将从2025年的188.1亿美元成长到2034年的430.7亿美元，2026年至2034年的复合年增长率为9.64%。

受精准医疗、疾病早期检测和基因筛检需求成长的推动，全球DNA诊断市场正经历显着扩张。遗传性疾病、癌症和感染疾病的日益普及加速了分子诊断技术的应用。次世代定序（NGS）、基于PCR的检测和基于CRISPR的诊断平台的进步提高了准确性和反应速度。人们对个人化治疗和预防医学的日益重视，进一步推动了已开发经济体和新兴经济体的市场渗透率。

关键成长要素包括新生儿筛检计画的扩展、基因组研究投资的增加以及人工智慧（AI）在基因数据分析中的应用。製药公司正在加强DNA诊断技术在伴随诊断和标靶药物开发的应用。此外，定序成本的降低和检查室自动化技术的进步也提高了人们获得先进基因检测的机会。政府鼓励基因组研究和人群健康筛检计画的政策正在创造有利的监管和资金筹措环境。

展望未来，肿瘤学、罕见疾病、生殖医学和药物遗传学等领域的应用拓展预计将推动市场成长。家用基因检测套组和直接面向消费者的检测服务的普及可能会重塑整个产业格局。生物技术公司、研究机构和医疗服务提供者之间的策略合作将加速创新。随着个人化医疗逐渐成为主流，DNA诊断预计仍将在全球预测性、预防性和精准医疗模式中发挥核心作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球DNA诊断市场：依产品/服务分类

  • 市场分析、洞察与预测
  • 装置
  • 试剂和试剂盒
  • 服务和软体

第五章 全球DNA诊断市场：依技术划分

  • 市场分析、洞察与预测
  • 原位杂合反应
  • 质谱分析
  • 微阵列
  • 聚合酵素链锁反应（PCR）
  • 定序
  • 其他的

第六章 全球DNA诊断市场：依应用划分

  • 市场分析、洞察与预测
  • 癌症基因检测
  • 感染疾病DNA检测
  • 新生儿基因筛检
  • 胚胎着床前诊断与辅助生殖技术诊断
  • 非传染性疾病的DNA检测
  • 血液学/免疫学/身份验证/法医学
  • 药物基因学/药物代谢
  • 产前DNA携带者筛检
  • 其他的

第七章 全球DNA诊断市场：依检体类型划分

  • 市场分析、洞察与预测
  • 血液、血清和血浆
  • 尿
  • 其他的

第八章 全球DNA诊断市场：依最终用户划分

  • 市场分析、洞察与预测
  • 诊断检查室
  • 医院和诊所
  • 其他的

第九章 全球DNA诊断市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 亚太其他地区
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十一章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Abbott Laboratories
    • Agilent Technologies Inc
    • Avalon GloboCare Corp
    • Beckman Coulter Inc
    • Bio-Rad Laboratories Inc
    • Cepheid
    • F. Hoffmann-La Roche Ltd
    • GE HealthCare Technologies Inc
    • Hologic Inc
    • Illumina Inc
    • Siemens Healthineers（Formerly Siemens Healthcare Private Limited）
    • Thermo Fisher Scientific Inc
简介目录
Product Code: VMR112112254

The DNA Diagnostics Market size is expected to reach USD 43.07 Billion in 2034 from USD 18.81 Billion (2025) growing at a CAGR of 9.64% during 2026-2034.

The Global DNA Diagnostics Market is witnessing strong expansion driven by rising demand for precision medicine, early disease detection, and genetic screening. Increasing prevalence of hereditary disorders, cancer, and infectious diseases has accelerated the adoption of molecular diagnostic technologies. Advancements in next-generation sequencing (NGS), PCR-based testing, and CRISPR-based diagnostic platforms are improving accuracy and turnaround time. Growing awareness regarding personalized treatment approaches and preventive healthcare is further supporting market penetration across developed and emerging economies.

Key growth drivers include expanding newborn screening programs, increasing investments in genomics research, and the integration of artificial intelligence in genetic data interpretation. Pharmaceutical companies are increasingly leveraging DNA diagnostics for companion diagnostics and targeted drug development. Moreover, declining sequencing costs and improved laboratory automation are making advanced genetic tests more accessible. Government initiatives promoting genomic research and population health screening programs are creating favorable regulatory and funding environments.

Looking ahead, the market is expected to benefit from expanding applications in oncology, rare diseases, reproductive health, and pharmacogenomics. The shift toward home-based genetic testing kits and direct-to-consumer testing services is likely to reshape industry dynamics. Strategic collaborations between biotechnology firms, research institutes, and healthcare providers will accelerate innovation. As personalized healthcare becomes mainstream, DNA diagnostics will remain central to predictive, preventive, and precision medicine models worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Offering

  • Instruments
  • Reagents & Kits
  • Services & Software

By Technology

  • In Situ Hybridization
  • Mass Spectroscopy
  • Microarrays
  • Polymerase Chain Reaction (PCR)
  • Sequencing
  • Others

By Application

  • Cancer Genetics Tests
  • Infectious Diseases DNA Testing
  • Newborn Genetic Screening
  • Preimplantation & Reproductive Diagnosis
  • Non-Infectious Diseases DNA Testing
  • Hematology & Immunology/Identity Diagnostics & Forensics
  • Pharmacogenomics/Drug Metabolism
  • Prenatal DNA Carrier Screening
  • Others

By Specimen

  • Blood, Serum, and Plasma
  • Urine
  • Others

By End User

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, Agilent Technologies Inc, Avalon GloboCare Corp, Beckman Coulter Inc, BioRad Laboratories Inc, Cepheid, F HoffmannLa Roche Ltd, GE HealthCare Technologies Inc, Hologic Inc, Illumina Inc, Siemens Healthineers formerly Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA DIAGNOSTICS MARKET: BY OFFERING 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Offering
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services & Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. In Situ Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Mass Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Cancer Genetics Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Infectious Diseases DNA Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Newborn Genetic Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Preimplantation & Reproductive Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Non-Infectious Diseases DNA Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Hematology & Immunology/Identity Diagnostics & Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.8. Pharmacogenomics/Drug Metabolism Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.9. Prenatal DNA Carrier Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA DIAGNOSTICS MARKET: BY SPECIMEN 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Specimen
  • 7.2. Blood, Serum, and Plasma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DNA DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Offering
    • 9.2.2 By Technology
    • 9.2.3 By Application
    • 9.2.4 By Specimen
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Offering
    • 9.3.2 By Technology
    • 9.3.3 By Application
    • 9.3.4 By Specimen
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Offering
    • 9.4.2 By Technology
    • 9.4.3 By Application
    • 9.4.4 By Specimen
    • 9.4.5 By End User
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Offering
    • 9.5.2 By Technology
    • 9.5.3 By Application
    • 9.5.4 By Specimen
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Offering
    • 9.6.2 By Technology
    • 9.6.3 By Application
    • 9.6.4 By Specimen
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DNA DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Abbott Laboratories
    • 11.2.2 Agilent Technologies Inc
    • 11.2.3 Avalon GloboCare Corp
    • 11.2.4 Beckman Coulter Inc
    • 11.2.5 Bio-Rad Laboratories Inc
    • 11.2.6 Cepheid
    • 11.2.7 F. Hoffmann-La Roche Ltd
    • 11.2.8 GE HealthCare Technologies Inc
    • 11.2.9 Hologic Inc
    • 11.2.10 Illumina Inc
    • 11.2.11 Siemens Healthineers (Formerly Siemens Healthcare Private Limited)
    • 11.2.12 Thermo Fisher Scientific Inc